Standard
Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis. / Hansen, Henning G; Overgaard, Julie; Lajer, Maria; Hubalek, Frantisek; Højrup, Peter; Pedersen, Lykke; Tarnow, Lise; Rossing, Peter; Pociot, Flemming; McGuire, James N.
In:
Proteomics - Clinical Applications, Vol. 4, No. 8-9, 01.09.2010, p. 697-705.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Hansen, HG, Overgaard, J, Lajer, M, Hubalek, F, Højrup, P, Pedersen, L, Tarnow, L
, Rossing, P, Pociot, F & McGuire, JN 2010, '
Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis',
Proteomics - Clinical Applications, vol. 4, no. 8-9, pp. 697-705.
https://doi.org/10.1002/prca.200900169APA
Hansen, H. G., Overgaard, J., Lajer, M., Hubalek, F., Højrup, P., Pedersen, L., Tarnow, L.
, Rossing, P., Pociot, F., & McGuire, J. N. (2010).
Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.
Proteomics - Clinical Applications,
4(8-9), 697-705.
https://doi.org/10.1002/prca.200900169Vancouver
Hansen HG, Overgaard J, Lajer M, Hubalek F, Højrup P, Pedersen L et al.
Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.
Proteomics - Clinical Applications. 2010 Sep 1;4(8-9):697-705.
https://doi.org/10.1002/prca.200900169Author
Hansen, Henning G ; Overgaard, Julie ; Lajer, Maria ; Hubalek, Frantisek ; Højrup, Peter ; Pedersen, Lykke ; Tarnow, Lise ; Rossing, Peter ; Pociot, Flemming ; McGuire, James N. / Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis. In: Proteomics - Clinical Applications. 2010 ; Vol. 4, No. 8-9. pp. 697-705.
Bibtex
@article{4ce46aceb64b484aa2adffc05fe7d4a0,
title = "Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis",
abstract = "Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and improved biomarkers would help identify high-risk individuals. The aim of this study was to discover candidate biomarkers for DN in the plasma peptidome in an in-house cross-sectional cohort (n=122) of type 1 diabetic patients diagnosed with normo-, micro-, and macroalbuminuria.",
author = "Hansen, {Henning G} and Julie Overgaard and Maria Lajer and Frantisek Hubalek and Peter H{\o}jrup and Lykke Pedersen and Lise Tarnow and Peter Rossing and Flemming Pociot and McGuire, {James N}",
note = "Copyright {\textcopyright} 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.",
year = "2010",
month = sep,
day = "1",
doi = "10.1002/prca.200900169",
language = "English",
volume = "4",
pages = "697--705",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley - V C H Verlag GmbH & Co. KGaA",
number = "8-9",
}
RIS
TY - JOUR
T1 - Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis
AU - Hansen, Henning G
AU - Overgaard, Julie
AU - Lajer, Maria
AU - Hubalek, Frantisek
AU - Højrup, Peter
AU - Pedersen, Lykke
AU - Tarnow, Lise
AU - Rossing, Peter
AU - Pociot, Flemming
AU - McGuire, James N
N1 - Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2010/9/1
Y1 - 2010/9/1
N2 - Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and improved biomarkers would help identify high-risk individuals. The aim of this study was to discover candidate biomarkers for DN in the plasma peptidome in an in-house cross-sectional cohort (n=122) of type 1 diabetic patients diagnosed with normo-, micro-, and macroalbuminuria.
AB - Diabetic nephropathy (DN) is the most common cause of end-stage renal disease and improved biomarkers would help identify high-risk individuals. The aim of this study was to discover candidate biomarkers for DN in the plasma peptidome in an in-house cross-sectional cohort (n=122) of type 1 diabetic patients diagnosed with normo-, micro-, and macroalbuminuria.
U2 - 10.1002/prca.200900169
DO - 10.1002/prca.200900169
M3 - Journal article
C2 - 21137087
VL - 4
SP - 697
EP - 705
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
SN - 1862-8346
IS - 8-9
ER -
